Success Metrics

Clinical Success Rate
80.6%

Based on 25 completed trials

Completion Rate
81%(25/31)
Active Trials
11(16%)
Results Posted
20%(5 trials)
Terminated
6(9%)

Phase Distribution

Ph phase_3
5
7%
Ph phase_1
5
7%
Ph phase_2
20
30%
Ph phase_4
10
15%
Ph not_applicable
23
34%
Ph early_phase_1
4
6%

Phase Distribution

9

Early Stage

20

Mid Stage

15

Late Stage

Phase Distribution67 total trials
Early Phase 1First-in-human
4(6.0%)
Phase 1Safety & dosage
5(7.5%)
Phase 2Efficacy & side effects
20(29.9%)
Phase 3Large-scale testing
5(7.5%)
Phase 4Post-market surveillance
10(14.9%)
N/ANon-phased studies
23(34.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

64.1%

25 of 39 finished

Non-Completion Rate

35.9%

14 ended early

Currently Active

11

trials recruiting

Total Trials

67

all time

Status Distribution
Active(17)
Completed(25)
Terminated(14)
Other(11)

Detailed Status

Completed25
unknown11
Withdrawn8
Active, not recruiting8
Not yet recruiting6
Terminated6

Development Timeline

Analytics

Development Status

Total Trials
67
Active
11
Success Rate
80.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (6.0%)
Phase 15 (7.5%)
Phase 220 (29.9%)
Phase 35 (7.5%)
Phase 410 (14.9%)
N/A23 (34.3%)

Trials by Status

not_yet_recruiting69%
recruiting34%
terminated69%
unknown1116%
withdrawn812%
completed2537%
active_not_recruiting812%

Recent Activity

Clinical Trials (67)

Showing 20 of 67 trialsScroll for more
NCT06634823Early Phase 1

Efficacy of Intramuscular Steroid Injection for Chronic Cough.

Recruiting
NCT05866536Phase 2

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

Active Not Recruiting
NCT05180591Phase 2

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

Active Not Recruiting
NCT07086677Phase 1

A Study to Learn About How a New Pneumococcal Vaccine Works in Adults

Active Not Recruiting
NCT05894265Not Applicable

Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair

Recruiting
NCT05037812Early Phase 1

Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures

Active Not Recruiting
NCT07528794Not Applicable

Ultrasound-Guided Lumbar Facet Joint Injections for Facet-Related Pain: A Randomized Comparison of Saline, Steroid, and 5% Dextrose

Completed
NCT02081326Phase 2

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

Active Not Recruiting
NCT07488988Phase 2

SCARFREE-001: Verteporfin for Scar Prevention

Not Yet Recruiting
NCT04409600Phase 2

Comparison of Non-Surgical Treatment Options for Chronic Exertional Compartment Syndrome (CECS)

Completed
NCT07352241Not Applicable

Repeated Injections of i-PRF for Decreasing Root Resorption After the Orthodontic Treatment.

Completed
NCT02907983Phase 2

Stellate Ganglion Blockade in Post-Menopausal Women

Withdrawn
NCT06121882Phase 3

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

Active Not Recruiting
NCT06774807Not Applicable

Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)

Completed
NCT04513145Phase 2

Adductor Canal Block

Active Not Recruiting
NCT03582085Phase 2

Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia

Withdrawn
NCT06620874Not Applicable

Comparison of the Efficacy of Ultrasound-Guided Injections of Saline, High-Concentration Dextrose, and Ligament Repair Agents for the Treatment of Medial Collateral Ligament Pathology in Degenerative Knee Osteoarthritis: A Randomized Double-Blind Trial.

Not Yet Recruiting
NCT04744675Phase 2

Peripheral Nerve Injections for CRPS

Active Not Recruiting
NCT03743025Phase 4

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

Terminated
NCT00119067Phase 4

Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change

Completed

Drug Details

Intervention Type
DRUG
Total Trials
67